Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ejeBCfbwocfalIlpLpbB

February 1, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Stories 
  • PCMA: Restricting biosimilars will hurt consumers
    If drugmakers succeed in a campaign to pass state laws governing dispensing of less costly biosimilar drugs, patients and taxpayers will pay the price, PCMA President and CEO Mark Merritt said. "Campaigning to restrict the use of biosimilars enriches brand manufacturers at the expense of the employers, public health programs and patients who need access to lower-cost medicines," Merritt said. American City Business Journals/Dayton, Ohio (1/31) LinkedInFacebookTwitterEmail this Story
  • Drugstore lobby poll finds support for money-saving mail-order drugs
    The National Community Pharmacists Association argues Medicare beneficiaries do not want to receive their prescription drugs in the mail, but their own survey shows otherwise. When asked, Medicare beneficiaries agree that mail-service pharmacies are less expensive than retail pharmacies. "When the drugstore lobby admits that mail-service pharmacies cost less than local drugstores, it's time to remove Medicare barriers that keep seniors from accessing home delivery," said PCMA President and CEO Mark Merritt in a statement. InsideHealthPolicy.com (subscription required) (2/1) LinkedInFacebookTwitterEmail this Story
 Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!
 

  Legislative & Regulatory News 
  • 39 states have yet to act on ACA's consumer protections
    Just 11 states have made efforts to enforce consumer safeguards under the Affordable Care Act, leading to concerns about the implementation of major health insurance provisions such as limits on out-of-pocket costs and coverage of pre-existing conditions, according to a report from the Commonwealth Fund. Thirty-nine states haven't released regulations or passed laws on seven coverage provisions. Among the provisions are a ban on coverage waiting periods; restrictions against basing costs on health condition, age or gender; and a requirement to cover 60% or more of costs. Reuters (2/1) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  SmartQuote 
Never confuse a single defeat with a final defeat."
--F. Scott Fitzgerald,
American writer


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information